NCT03169166View on ClinicalTrials.gov

The Use of GnRH Agonist Trigger for Final Follicle Maturation in Women Undergoing Assisted Reproductive Technologies

PHASE4CompletedINTERVENTIONAL

Enrollment

277

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

July 1, 2021

Study Completion Date

October 1, 2021

Conditions

SterilityInfertility

Interventions

DRUG

Triptorelin

Triptorelin pre-filled syringes (Gonapeptyl 0.1mg; Ferring GmbH, Germany) will be administered subcutaneously in three repeated doses 12 hours apart

Trial Locations (1)

Unknown

American University of Beirut Medical Center, Beirut

All Listed Sponsors

lead

American University of Beirut Medical Center

OTHER

NCT03169166 - The Use of GnRH Agonist Trigger for Final Follicle Maturation in Women Undergoing Assisted Reproductive Technologies | Biotech Hunter | Biotech Hunter